Skip to main content

Advertisement

Table 4 Sub-hazard ratio of statin, ACEi, ARB, ACEi or ARB, or any cardioprotective medication use in the 1 year following a diabetes diagnosis for women relative to men

From: Sex-based disparities in cardioprotective medication use in adults with diabetes

N = 33,294 Crude SHR (95% CI) Adjusted* SHR (95% CI)
   Statin 0.90 (0.86 – 0.95) 0.90 (0.85 – 0.96)
   ACEi 0.91 (0.87 – 0.95) 0.90 (0.86 – 0.94)
   ARB 1.34 (1.24 – 1.43) 1.08 (0.99 – 1.17)
 ACEi or ARB 1.00 (0.97 – 1.04) 0.93 (0.89 – 0.97)
Any of the above 1.00 (0.97 – 1.04) 0.93 (0.90 – 0.97)
  1. *Adjusted for age at diabetes diagnosis, cardiovascular disease status, Chronic Disease Score, renal disease, dialysis, physician office visits, hospitalizations, days in hospital, day surgeries (all )in the 3 years prior to diabetes diagnosis, year of diabetes diagnosis and pre-existing prescription for the same medication at baseline.
  2. Abbreviations: ACEi angiotensin-converting-enzyme inhibitors, ARB angiotensin receptor blockers, SHR sub-hazard ratio.